No Data
No Data
No Data
No Data
No Data
Express News | CorMedix Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024
ReutersMay 6 08:30 ET
Earnings Week Ahead: Disney, Palantir, Shopify, Uber, Plug Power and More
Seeking AlphaMay 5 08:00 ET
CorMedix Shares Rise 6% After DefenCath Meets Payment Criteria
By Chris Wack CorMedix shares were up 6% to $5.73 after the company said that the Center for Medicare & Medicaid Services has determined that its DefenCath product meets the criteria for a transition
WSJApr 19 10:50 ET
CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow JonesApr 19 08:35 ET
CorMedix: TDAPA Program Provides for Five Years Additional Payment Reimbursement >CRMD
CorMedix: TDAPA Program Provides for Five Years Additional Payment Reimbursement >CRMD
Dow JonesApr 19 08:34 ET
Express News | CorMedix Inc. Announces CMS Grants Transitional Drug Add-On Payment To DefenCath
Moomoo 24/7Apr 19 08:31 ET
Revelation 6 : Did they get bad news on their trail?
No Data
No Data